Symbol
| ROCK1
| contributors: mct/pgu - updated : 21-05-2018
|
HGNC name
| Rho-associated, coiled-coil containing protein kinase 1
|
HGNC id
| 10251
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
|  
| loss of function
|
causes whole body insulin resistance by impairing insulin signaling in skeletal muscle, suggesting that activation of ROCK1 is essential for the normal actions of insulin on glucose transport in skeletal muscle | tumoral
| somatic mutation
|  
|  
| gain of function
|
three somatic mutations leading to elevated kinase activity and driving actin cytoskeleton rearrangements that promote increased motility and decreased adhesion (characteristics of cancer progression) | tumoral
|  
|  
| --over
|  
|
in various tumor cell lines and tumor tissues from osteosarcoma patients | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | reproductive | breast | |
potential target in breast cancer | immunology | inflammatory | | |
may represent a promising therapeutic target in vascular inflammatory diseases | cancer | bone | | |
may be a promising therapeutic target for the treatment of osteosarcoma patients. | neuromuscular | spinal muscular atrophy | | |
therapeutic potential of ROCK1 inhibition in SMA | neurology | neurodegenerative | huntington chorea | |
A signaling pathway from ROCK1 to profilin thus controls polyglutamine protein aggregation and is targeted by a promising therapeutic lead for HD |
| | | |
| ROCK1-deficient mice exhibited insulin resistance, as revealed by the failure of blood glucose levels to decrease after insulin injection |